TapImmune Inc.
TapImmune Inc. Rated 'Speculative Buy,' Target Price $0.85 by Beacon Equity Research
Published in Vaccine Weekly, June 18th, 2008
The full report is available at http://www.BeaconEquity.com.
Anyone interested in receiving alerts regarding TapImmune Inc. research should e-mail members@beaconequity.com with "TPIM" in the subject line.
In the report, the analyst writes, "The Company recently received positive news from the U.S. Patent office regarding key follow on patents and has also filed additional patent applications that further strengthen and expand its IP portfolio ...
"TPIM also benefits from...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-06-18)
More Articles from Vaccine Weekly
- University of Texas Medical Branch at Galveston
New West Nile and Japanese encephalitis vaccines produced - Angiogenesis
New angiogenesis research from T. Levchenko and colleagues discussed - Burkholderia
Research on Burkholderia published by scientists at University of Georgia - Cancer Vaccines
Bavarian Nordic Enters Clinical Trials With Prostate Cancer Vaccine - Cancer Vaccines
BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine - Escherichia coli
Data on Escherichia coli published by researchers at Novartis - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
